Wall Street analysts expect that Stepan (NYSE:SCL) will announce $501.20 million in sales for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Stepan’s earnings. The highest sales estimate is $513.70 million and the lowest is $488.70 million. Stepan reported sales of $508.00 million in the same quarter last year, which indicates a negative year-over-year growth rate of 1.3%. The business is expected to announce its next quarterly earnings report on Wednesday, October 23rd.
According to Zacks, analysts expect that Stepan will report full year sales of $1.94 billion for the current financial year, with estimates ranging from $1.92 billion to $1.97 billion. For the next financial year, analysts expect that the company will report sales of $2.08 billion, with estimates ranging from $2.01 billion to $2.16 billion. Zacks’ sales averages are a mean average based on a survey of research firms that follow Stepan.
Stepan (NYSE:SCL) last issued its earnings results on Wednesday, July 24th. The basic materials company reported $1.50 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.31 by $0.19. The company had revenue of $473.00 million for the quarter, compared to analysts’ expectations of $519.20 million. Stepan had a net margin of 5.39% and a return on equity of 14.19%. The firm’s revenue was down 9.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.38 earnings per share.
A number of analysts have weighed in on SCL shares. Scotiabank cut shares of Stepan to a “sector underperform” rating and set a $20.00 target price on the stock. in a report on Tuesday, August 13th. ValuEngine lowered shares of Stepan from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Royal Bank of Canada started coverage on shares of Stepan in a research report on Wednesday, July 3rd. They set a “sector perform” rating and a $21.00 price target for the company. Zacks Investment Research upgraded shares of Stepan from a “sell” rating to a “hold” rating in a research report on Wednesday, July 24th. Finally, BMO Capital Markets lowered their price target on shares of Stepan from $28.00 to $20.00 and set an “outperform” rating for the company in a research report on Friday, August 9th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $54.14.
Shares of NYSE:SCL traded down $0.43 on Thursday, reaching $96.78. 76,399 shares of the company’s stock were exchanged, compared to its average volume of 86,034. The firm has a market capitalization of $2.19 billion, a price-to-earnings ratio of 19.83 and a beta of 1.30. Stepan has a fifty-two week low of $69.17 and a fifty-two week high of $101.84. The business’s 50-day moving average is $95.50 and its two-hundred day moving average is $91.44. The company has a quick ratio of 1.97, a current ratio of 2.69 and a debt-to-equity ratio of 0.28.
The company also recently declared a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 30th were given a dividend of $0.25 per share. The ex-dividend date was Thursday, August 29th. This represents a $1.00 annualized dividend and a dividend yield of 1.03%. Stepan’s dividend payout ratio is currently 20.49%.
In other news, VP Sean Thomas Moriarty sold 1,961 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $99.30, for a total transaction of $194,727.30. Following the completion of the transaction, the vice president now owns 5,077 shares in the company, valued at $504,146.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Scott R. Behrens sold 2,004 shares of the stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $97.39, for a total transaction of $195,169.56. Following the completion of the transaction, the vice president now owns 13,825 shares of the company’s stock, valued at approximately $1,346,416.75. The disclosure for this sale can be found here. Insiders have sold 21,180 shares of company stock valued at $2,074,308 in the last 90 days. Insiders own 11.40% of the company’s stock.
A number of institutional investors and hedge funds have recently made changes to their positions in SCL. Dimensional Fund Advisors LP grew its position in Stepan by 0.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,097,483 shares of the basic materials company’s stock valued at $81,214,000 after buying an additional 3,653 shares in the last quarter. Geode Capital Management LLC grew its position in Stepan by 6.2% in the 4th quarter. Geode Capital Management LLC now owns 274,456 shares of the basic materials company’s stock valued at $20,309,000 after buying an additional 15,923 shares in the last quarter. BNP Paribas Arbitrage SA grew its position in Stepan by 215.0% in the 1st quarter. BNP Paribas Arbitrage SA now owns 4,735 shares of the basic materials company’s stock valued at $414,000 after buying an additional 3,232 shares in the last quarter. SG Americas Securities LLC bought a new position in Stepan in the 1st quarter valued at about $233,000. Finally, Rhumbline Advisers grew its position in Stepan by 1.7% in the 1st quarter. Rhumbline Advisers now owns 65,838 shares of the basic materials company’s stock valued at $5,762,000 after buying an additional 1,100 shares in the last quarter. Hedge funds and other institutional investors own 74.56% of the company’s stock.
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia. The company operates through three segments: Surfactants, Polymers, and Specialty Products.
Read More: What is a Market Correction?
Get a free copy of the Zacks research report on Stepan (SCL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.